ECM Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (K253521) for ECMT-100 WMD, a flowable extracellular matrix hydrogel intended for the ...
The bone extracellular matrix (ECM) contains minerals deposited on highly crosslinked collagen fibrils and hundreds of non-collagenous proteins. Some of these proteins are key to the regulation of ...
Despite numerous advances in our understanding of cardiovascular biology, heart disease remains the leading cause of morbidity and mortality worldwide 1,2. Following acute myocardial infarction in the ...
Collaboration leverages Engitix’s human ECM Platform to identify high-confidence targets for liver fibrosis regressionLONDON, June 08, 2026 (GLOBE NEWSWIRE) -- Engitix Ltd. (“Engitix”), a ...
Activities are intended to support regulatory testing and the Company’s planned first-quarter 2027 FDA 510(k) premarket ...
Definition: The extracellular matrix is the non-cellular network of proteins and polysaccharides that surrounds cells, gives tissues mechanical structure, and provides biochemical and mechanical ...
A new study, led by Prof. Liu from the department of pharmacy, University of Electronic Science and Technology of China, discovered that the extracellular cell matrix (ECM) could induce the drug ...
Vasa Therapeutics ("Vasa"), a clinical stage biotechnology company developing novel therapies for cardiovascular and metabolic aging, announced today that Noreen R. Henig, MD, Chief Medical Officer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results